A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred

Jan 1, 1988·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·G M PatrassiA Girolami

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors

Oct 1, 1995·Annals of Hematology·A CasonatoA Girolami

Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature

Apr 9, 2005·Journal of Thrombosis and Thrombolysis·A GirolamiF Fabris

Factor X antigen evaluation by means of a laser nephelometer in health and disease

May 30, 1985·Clinica Chimica Acta; International Journal of Clinical Chemistry·A GirolamiM A Vicarioto

A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)-->Asn) in the factor X gene. A study of an Italian family

Mar 15, 2001·Thrombosis Research·P SimioniA Girolami

Conformation sensitive gel electrophoresis for detection of factor X gene mutations

Nov 5, 2002·Thrombosis Research·Fabrizio VianelloAntonio Girolami

Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z

Sep 28, 1999·Thrombosis Research·E Lechler

Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation

Aug 19, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·T M SartoriG Antonio

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

Mar 12, 2002·British Journal of Haematology·A CasonatoA Girolami

A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy

Feb 22, 1979·The New England Journal of Medicine·J I BrodyR E Rossman

Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration

Dec 1, 1972·British Journal of Haematology·M LevanonE Goldberg

Factor X Roma: a congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activation

Jul 1, 1988·British Journal of Haematology·V De StefanoB Bizzi

Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain

Aug 1, 1995·British Journal of Haematology·G MarchettiF Bernardi

Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille)

Nov 15, 1995·European Journal of Biochemistry·A BezeaudM C Guillin

Factor X deficiency in a Jack Russell terrier

Jan 1, 1993·Veterinary Clinical Pathology·Audrey K. CookBernard F. Feldman

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

Feb 5, 2008·Blood·Lisa GallinaroAlessandra Casonato

A family with heterozygous factor X Friuli defect outside Friuli

Mar 1, 1983·Blut·A GirolamiG Luzzatto

Increased factor VIII/vWf levels in patients with reduced platelet number

May 1, 1987·Blut·A CasonatoA Girolami

A new family with classical factor X deficiency as demonstrated by electroimmunoassay

Jul 1, 1983·Blut·A GirolamiF A Zanolli

The effect of low-dose estroprogestinic preparations on prothrombin complex factors: no significant increase after an 8-month trial

Mar 1, 1985·Blut·A GirolamiT Vicari

Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley

Jun 1, 1982·Blut·A GirolamiP Saltarin

An immunological investigation of factor VIII associated antigen in combined factor V and factor VIII deficiency

Aug 1, 1976·Blut·A GirolamiA Sticchi

Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques

Aug 1, 1972·Blut·A GirolamiG Bareggi

Hemophilia B+ or Bm. First case reported in Italy

Apr 1, 1973·Blut·A GirolamiG Bareggi

Factor X Friuli coagulation disorder. First report of a patient born in Friuli after the description of the disease

Sep 1, 1973·Blut·A GirolamiL De Marco

Dilution curve studies in prothrombin complex factors deficiencies and abnormalities

Aug 1, 1974·Blut·A GirolamiD Fioretti

Factor VIII immunological assay. An evaluation of several methods using whole plasma

Nov 1, 1974·Blut·A GirolamiG Bareggi

Factor X Friuli: An immunological study in plasma and in serum using several methods

Mar 1, 1975·Blut·A GirolamiN Borsato

The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex

Nov 1, 1975·Blut·A GirolamiF Cafiero

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor

Sep 19, 2014·Thrombosis and Haemostasis·V DaidoneA Casonato

Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era

Jun 16, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·A GirolamiA M Lombardi

A cluster of factor XI-deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy

Oct 18, 2011·European Journal of Haematology·Antonio GirolamiAnna Maria Lombardi

A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba

Mar 20, 2010·American Journal of Hematology·Antonio GirolamiAnna Maria Lombardi

Rectus muscle sheath haematoma in a patient with congenital FX deficiency and in another with congenital FVII deficiency

Nov 3, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·A GirolamiR Scandellari

The rarer inherited coagulation disorders: a review

Jun 1, 1995·Blood Reviews·P H Bolton-Maggs, F G Hill

Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses

Feb 1, 1985·British Journal of Haematology·D S Fair, T S Edgington

Inherited bleeding disorders

Apr 1, 1991·Baillière's Clinical Haematology·V S BlanchetteC Turner

Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis

May 1, 1986·British Journal of Haematology·F FabrisA Girolami

Novel factor X deficiency. Normal partial thromboplastin time and associated spindle cell thymoma

Jul 1, 1985·The American Journal of Medicine·R E NoraP W Sholar

Factor X deficiency

Jul 20, 2002·Blood Reviews·James Uprichard, David J Perry

Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)

Apr 29, 2016·European Journal of Haematology·Antonio GirolamiAnna Maria Lombardi

Factor X Friuli Coagulation Disorder: Almost 50 Years Later

Dec 30, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Antonio GirolamiAnna Maria Lombardi

Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor

Jun 1, 1992·Thrombosis Research·G M PatrassiA Girolami

Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers

Feb 1, 1997·The Journal of Laboratory and Clinical Medicine·A CasonatoA Girolami

A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A

Feb 26, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Anna Maria LombardiAntonio Girolami

A new mutation (Arg251Trp) in the Ca2+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of factor X Padua

Feb 26, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Antonio GirolamiAnna Maria Lombardi

Selected topics on blood coagulation

Aug 1, 1973·CRC Critical Reviews in Biochemistry·E Triantaphyllopoulos, D C Triantaphyllopoulos

Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding

Apr 9, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A CasonatoA Girolami

Unexplained discrepancies in the activity--antigen ratio in congenital FX deficiencies with defects in the catalytic domain

Aug 12, 2009·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·A GirolamiA M Lombardi

❮ Previous

Next ❯

Related Concepts

Related Feeds

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

A "new" congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred

Abstract

References

Haemophilia Bm: a new type of factor-IX deficiency

A new inherited coagulation disorder caused by an abnormal fibrinogen ('fibrinogen Baltimore')

An investigation of three patients with Christmas disease due to an abnormal type of factor IX

Congenital haemorrhagic condition similar but not identical to factor X deficiency. A haemorrhagic state due to an abnormal factor X?

Fibrinolytic and proteolytic activity of a human plasminogen, prepared from fraction III of human plasma

A new coagulation defect

Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency

Stuart clotting defect. II. Genetic aspects of a new hemorrhagic state

A rapid screening test for disorders of thromboplastin generation

Familial deficiency of factor X

The specific assay of Prower-Stuart factor and factor VII

The Stuart-Prower factor: utilization of clotting factors obtained by starch-block electrophoresis for genetic evaluation

THE INHERITANCE OF STUART DISEASE: INVESTIGATION OF A FAMILY WITH FACTOR X DEFICIENCY

Morphology and enumeration of human blood platelets

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin

An improved one-stage prothrombin method

Citations

Immunohistochemical identification of factor X-like antigen in the A cells of the normal human pancreas

A DIC-like picture on plasma and ascitic fluid of cirrhotic patients

Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors

Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature

Factor X antigen evaluation by means of a laser nephelometer in health and disease

A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)-->Asn) in the factor X gene. A study of an Italian family

Conformation sensitive gel electrophoresis for detection of factor X gene mutations

Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z

Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation

Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome

A hemorrhagic syndrome in Waldenström's macroglobulinemia secondary to immunoadsorption of factor VIII. Recovery after splenectomy

Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration

Factor X Roma: a congenital factor X variant defective at different degrees in the intrinsic and the extrinsic activation

Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glu102Lys) in the second EGF-like domain

Functional consequences of the Ser334-->Pro mutation in a human factor X variant (factor XMarseille)

Factor X deficiency in a Jack Russell terrier

A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor.

A family with heterozygous factor X Friuli defect outside Friuli

Increased factor VIII/vWf levels in patients with reduced platelet number

A new family with classical factor X deficiency as demonstrated by electroimmunoassay

The effect of low-dose estroprogestinic preparations on prothrombin complex factors: no significant increase after an 8-month trial

Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley

An immunological investigation of factor VIII associated antigen in combined factor V and factor VIII deficiency

Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques

Hemophilia B+ or Bm. First case reported in Italy

Factor X Friuli coagulation disorder. First report of a patient born in Friuli after the description of the disease

Dilution curve studies in prothrombin complex factors deficiencies and abnormalities

Factor VIII immunological assay. An evaluation of several methods using whole plasma

Factor X Friuli: An immunological study in plasma and in serum using several methods

The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex

Loss of cysteine 584 impairs the storage and release, but not the synthesis of von Willebrand factor

Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era

A cluster of factor XI-deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy

A large family from Argentina with prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): prekallikrein Cordoba

Rectus muscle sheath haematoma in a patient with congenital FX deficiency and in another with congenital FVII deficiency

The rarer inherited coagulation disorders: a review

Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses

Inherited bleeding disorders

Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis

Novel factor X deficiency. Normal partial thromboplastin time and associated spindle cell thymoma

Factor X deficiency

Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years)

Factor X Friuli Coagulation Disorder: Almost 50 Years Later

Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor

Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers

A large deletion due to a new mutation (intron 13/exon 23) in a sporadic case of severe hemophilia A

A new mutation (Arg251Trp) in the Ca2+ binding site of factor X protease domain appears to be responsible for the defect in the extrinsic pathway activation of factor X Padua

Selected topics on blood coagulation

Plasma and platelet von Willebrand factor abnormalities in patients with uremia: lack of correlation with uremic bleeding

Unexplained discrepancies in the activity--antigen ratio in congenital FX deficiencies with defects in the catalytic domain

Related Concepts

Related Feeds

Blood Clotting Disorders

Related Papers

Factor X Padua: a 'new' congenital factor X abnormality with a defect only in the extrinsic system

The factor-X defect: recognition of abnormal forms of factor X

Factor X Friuli: An immunological study in plasma and in serum using several methods

Abnormal factor X(factor X Friuli) coagulation disorder

Polymorphism associated with the human coagulation factor X (F10) gene